• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cancer Cytopathol . Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study

tetano

Editor, Senior Moderator
Cancer Cytopathol


. 2021 Mar 10.
doi: 10.1002/cncy.22422. Online ahead of print.
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study


Valentina Canini[SUP] 1 [/SUP], Francesca Bono[SUP] 1 [/SUP], Paolo Calzavacca[SUP] 2 [/SUP], Giulia Capitoli[SUP] 3 [/SUP], Giuseppe Foti[SUP] 2 [/SUP], Filippo Fraggetta[SUP] 4 [/SUP], Stefania Galimberti[SUP] 3 [/SUP], Andrea Gianatti[SUP] 5 [/SUP], Marco Giani[SUP] 2 [/SUP], Ahmed Nasr[SUP] 1 [/SUP], Giuseppe Paciocco[SUP] 6 [/SUP], Fabio Pagni[SUP] 1 [/SUP], Roberto Rona[SUP] 2 [/SUP], Vincenzo L'Imperio[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Bronchoalveolar lavage (BAL) in patients with severe coronavirus disease 2019 (COVID-19) may provide additional and complementary findings for the management of these patients admitted to intensive care units (ICUs). This study addresses the cytological features of the infection and highlights the more influential inflammatory components. The correlation between pathological variables and clinical data is also analyzed.
Methods: The authors performed a retrospective analysis of the cytopathological features of BAL in 20 COVID-19 patients and 20 members of a matched cohort from a critical ICU who had acute respiratory distress syndrome caused by other pulmonary conditions.
Results: A comparison of the controls (n = 20) and the COVID-19 patients (n = 20) revealed that the latter had a higher neutrophil count (median, 63.8% of the cell count) with lower percentages of macrophages and lymphocytes. An increase in the expression of CD68-positive, monocytic multinucleated giant cells (MGCs) was reported; megakaryocytes were not detected on CD61 staining. Perls staining showed isolated elements. In situ RNA analysis demonstrated scattered chromogenic signals in type II pneumocytes. An ultrastructural analysis confirmed the presence of intracytoplasmic vacuoles containing rounded structures measuring 140 nm in diameter (putative viral particles). In COVID-19 patients, the clinicopathological correlation revealed a positive correlation between lactate dehydrogenase values and MGCs (r = 0.54).
Conclusions: The analysis of BAL samples might be implemented as a routine practice for the evaluation of COVID-19 patients in ICUs in the appropriate clinical scenario. Additional studies using a larger sample size of patients who developed COVID-19 during the second wave of the epidemic in the autumn of 2020 are needed to further support our findings.

Keywords: bronchoalveolar lavage (BAL); coronavirus disease 2019 (COVID-19); multinucleated giant cell; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
 
Back
Top Bottom